| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_21cfb7dd79973529725cde19b4f43cba |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04 |
| filingDate |
1989-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1991-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36ab8c03d1cf5b1dd7f6996c9bfbe1d0 |
| publicationDate |
1991-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-5041446-A |
| titleOfInvention |
Method for inhibiting the development of tolerance in the analgesic treatment with morphine |
| abstract |
Use of dapiprazole for the manufacture of a pharmaceutical composition inhibiting the development of tolerance in the analgesic treatment with morphine of a subject in need of said treatment. Pharmaceutical composition comprising from 2 to 20 mg of dapiprazole |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5321012-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5234927-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004024005-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-RE39300-E
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6730691-B1 |
| priorityDate |
1988-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |